Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
|Lexum European Eye Clinic, Czech Republic|
|ScientificTracks Abstracts: J Clin Exp Ophthalmol|
|Statement of the Problem: Central serous chorioretinopathy is easy to treat when the focus of leakage is obvious, however, in diffuse leakage the treatment is unknown. We use an individualized treatment for CSC based both on traditional procedures and on experimental ones. Laser stimulation therapy can be beneficial even in cases without the typical focus of leakage. Methods: A group of 88 patients with diagnosed CSC included various, very different findings. We excluded 20 eyes which healed spontaneously within several months and also 5 eyes where the finding was questionable and it more reminded AMD. We treated 30 eyes where the focus was clearly defined with focal laser, even in eyes where the focus was juxtafoveal – here we used threshold energy. In 9 eyes in which the focus could not be clearly defined, we used threshold or subthreshold laser into the anticipated focus. In 13 eyes with multiple leakage or diffuse leakage we used a “stimulation laser” in the areas of leakage, believing in the activation of the RPE leading to the sealing of the area of leakage. In 6 cases we first tried topical steroid drops in an intensive mode of application, i.e. every hour within one to two weeks, or Avastin, Triamcinolone, or Eylea injections. Results: The laser treatment was followed with a complete recovery not only in cases of focal treatment of the leakage point but also in the eyes with very chronic (even lasting seven years) leakage from undefined site. Steroid drops as a monotherapy also helped with healing of two patients but neither Avastin, nor Eylea and Triamcinolone did not bring a convincing effect. Take home message: CSC can be treated with laser not only in cases with clearly focal leakage but even in caser with poorly defined, only anticipated or diffuse leakage.|
Ivan Fiser graduated at the Charles University in Prague in 1985 and completed his surgical retinal training in 1993. He has been working as a director of vitreoretinal service at the 3rd Medical Faculty in Prague and since 2005 at the Lexum Eye Clinic. He completed his PhD in 2007. He has published more than 20 papers in journals and was the co-author of five textbooks. He has presented over 200 talks at home and abroad. He is a member of the board of the European vitreoretinal society and a previous member of the board of the Czech vitreoretinal society.
Email: [email protected]
|PDF | HTML|